艾奇资本 ACGL 深 沪
已收盘 08-01 16:00:00 美东时间
88.00
+1.940
+2.25%
华盛通- 最 高88.055
- 今 开86.38
- 成交量 284.68万股
- 最 低 86.285
- 昨 收 86.06
- 总市值 330.00亿
- 52周最高 111.47
- 市盈率 静 7.86
- 换手率 0.76%
- 52周最低 82.4925
- 委 比 -89.45%
- 总股本 3.75亿
- 历史最高 111.47
- 量 比 0.97
- 振 幅 2.06%
- 历史最低 5.0233
- 每 手 1
- 风险率 6.08%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Wells Fargo Maintains Overweight on Arch Capital Group, Lowers Price Target to $107
Wells Fargo analyst Elyse Greenspan maintains Arch Capital Group (NASDAQ:ACGL) with a Overweight and lowers the price target from $110 to $107.
07-31 23:27
Earnings Scheduled For July 29, 2025
Companies Reporting Before The Bell • Barclays (NYSE:BCS) is projected to repor...
07-29 16:32
Earnings Preview For Arch Capital Group
Arch Capital Group (NASDAQ:ACGL) will release its quarterly earnings report on ...
07-29 00:01
贝莱德私募基金的大投资者Arch试图退出
据知情人士透露，在业绩令人失望、高管离职之后，美国资产管理公司贝莱德旗下私募基金的一位主要投资者正在考虑减持。 其中一人称，至少持有10只贝莱德基金的份额、总部...
07-24 18:54
Price Over Earnings Overview: Arch Capital Group
In the current session, Arch Capital Group Inc. (NASDAQ:ACGL) is trading at $88...
07-19 00:00
Here is how June’s CPI data shows inflation pressures in tariff-exposed goods – Arch Capital’s Parker Ross
June’s U.S. CPI print showed that there is evidence of inflation pressures in the product categories that are most exposed to tariffs, said Parker Ross, global chief economist at Arch Capital Group. H...
07-15 22:31
Where Arch Capital Group Stands With Analysts
In the latest quarter, 8 analysts provided ratings for Arch Capital Group (NASD...
07-09 22:00
Keefe, Bruyette & Woods Downgrades Arch Capital Group to Market Perform, Lowers Price Target to $101
Keefe, Bruyette & Woods analyst Meyer Shields downgrades Arch Capital Group (NASDAQ:ACGL) from Outperform to Market Perform and lowers the price target from $113 to $101.
07-09 20:08
新浪财经ESG：艾奇资本 MSCI（明晟）ESG评级调升至AA
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...
06-27 07:00
美股大行评级 | 潜在涨幅434.95%！VNRX获Jones Trading首予"买入"评级，目标价3美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1139478829918380033.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Guggenheim：维持Metsera(MTSR)"买入"评级，目标价从56美元升至62美元</p> <p>• 摩根大通：维持Avidity Biosciences(RNA)"超配"评级，目标价从57美元升至59美元</
06-11 09:43
